268 related articles for article (PubMed ID: 28391067)
1. N-type Ca
Silva FR; Miranda AS; Santos RPM; Olmo IG; Zamponi GW; Dobransky T; Cruz JS; Vieira LB; Ribeiro FM
Neurobiol Aging; 2017 Jul; 55():1-10. PubMed ID: 28391067
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
[TBL] [Abstract][Full Text] [Related]
3. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
4. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Gray M; Shirasaki DI; Cepeda C; André VM; Wilburn B; Lu XH; Tao J; Yamazaki I; Li SH; Sun YE; Li XJ; Levine MS; Yang XW
J Neurosci; 2008 Jun; 28(24):6182-95. PubMed ID: 18550760
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease.
Soylu-Kucharz R; Baldo B; Petersén Å
Sci Rep; 2016 Jun; 6():28322. PubMed ID: 27334347
[TBL] [Abstract][Full Text] [Related]
6. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
[TBL] [Abstract][Full Text] [Related]
7. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
8. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
Wang J; Wang CE; Orr A; Tydlacka S; Li SH; Li XJ
J Cell Biol; 2008 Mar; 180(6):1177-89. PubMed ID: 18362179
[TBL] [Abstract][Full Text] [Related]
9. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
[TBL] [Abstract][Full Text] [Related]
10. αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.
Oliveira AO; Osmand A; Outeiro TF; Muchowski PJ; Finkbeiner S
Hum Mol Genet; 2016 May; 25(9):1677-89. PubMed ID: 26920069
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease.
Goodliffe J; Rubakovic A; Chang W; Pathak D; Luebke J
PLoS One; 2020; 15(6):e0234394. PubMed ID: 32574176
[TBL] [Abstract][Full Text] [Related]
12. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
[TBL] [Abstract][Full Text] [Related]
13. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
14. A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles.
Southwell AL; Skotte NH; Villanueva EB; Østergaard ME; Gu X; Kordasiewicz HB; Kay C; Cheung D; Xie Y; Waltl S; Dal Cengio L; Findlay-Black H; Doty CN; Petoukhov E; Iworima D; Slama R; Ooi J; Pouladi MA; Yang XW; Swayze EE; Seth PP; Hayden MR
Hum Mol Genet; 2017 Mar; 26(6):1115-1132. PubMed ID: 28104789
[TBL] [Abstract][Full Text] [Related]
15. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels.
Swayne LA; Chen L; Hameed S; Barr W; Charlesworth E; Colicos MA; Zamponi GW; Braun JE
Mol Cell Neurosci; 2005 Nov; 30(3):339-51. PubMed ID: 16162412
[TBL] [Abstract][Full Text] [Related]
17. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
[TBL] [Abstract][Full Text] [Related]
19. Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model.
Cheong RY; Baldo B; Sajjad MU; Kirik D; Petersén Å
Neuropathol Appl Neurobiol; 2021 Jun; 47(4):564-578. PubMed ID: 33330988
[TBL] [Abstract][Full Text] [Related]
20. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
